𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of chemokines in B cell chronic lymphocytic leukaemia: pathophysiological aspects and clinical impact

✍ Scribed by Percy Schröttner; Marion Leick; Meike Burger

Publisher
Springer
Year
2009
Tongue
English
Weight
461 KB
Volume
89
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of stem cell transplantation in
The role of stem cell transplantation in the management of chronic lymphocytic leukaemia
✍ Constantine S. Tam; Issa Khouri 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

## Abstract The majority of patients diagnosed with chronic lymphocytic leukaemia (CLL) will ultimately die of their disease. Stem cell transplantation (SCT) remains the only treatment modality capable of cure, but has traditionally been associated with very high morbidity and mortality. We review

Clinical relevance of the expression of
Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia
✍ Sherif Ibrahim; Iman Jilani; Susan O'Brien; Anna Rogers; Taghi Manshouri; Franci 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

## Abstract ## BACKGROUND CD31 (platelet endothelial cell adhesion molecule‐1 [PECAM‐1]) is the ligand for CD38, a transmembrane glycoprotein that is expressed on the surface of leukemic cells in many patients with B‐cell chronic lymphocytic leukemia (B‐CLL). In a previous study, the authors showe

Routine clinical use of alemtuzumab in p
Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia : A nation-wide retrospective study in Austria
✍ Michael Fiegl; Andreas Falkner; Georg Hopfinger; Stefan Brugger; August Zabernig 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 1 views

## Abstract ## BACKGROUND. In previous studies, alemtuzumab demonstrated considerable activity in patients with previously treated B‐cell chronic lymphocytic leukemia (CLL), including fludarabine‐refractory disease. In this retrospective study, the authors evaluated the benefit of alemtuzumab mono

Impact of trisomy 12, del(13q), del(17p)
Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia
✍ Sandra Quijano; Antonio López; Ana Rasillo; José María Sayagués; Susana Barrena; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

## Abstract B‐cell chronic lymphocytic leukemia (B‐CLL) is a well‐defined clinical entity with heterogeneous molecular and cytogenetic features. Here, we analyze the impact of trisomy 12, del(13q), del(17p), and del(11q) as determined by interphase fluorescence in situ hybridization analysis of pur